监测D-二聚体及小剂量肝素早期治疗小儿危重症的临床意义分析

Clinical Analysis of Monitoring D-dimer and Low-dose Heparin in Early Treating of Pediatric Critical Care

目的根据D-二聚体进行危重症评分,评价其监测价值,观察小剂量肝素对于治疗小儿危重症的效果和临床意义分析。方法选取我院在2013年2月至2014年2月收治的小儿危重症患者80例,随机分为实验组40例和对照组40例,对照组采用的是常规的临床治疗,实验组在常规治疗的基础上进行肝素治疗,对两组患者进行D-二聚体监测和其他凝血功能,观察肝素的治疗效果。结果两组患者在治疗后D-二聚体均有下降,血液凝血功能有效改善,实验组的治疗效果明显。结论 D-二聚体在危重症的监测中明显升高,小剂量肝素对于治疗小儿危重症具有明显的治疗效果,患者出现的不良反应少,值得临床推广和应用。

Objective According to the D-dimer for critical rating,evaluated its monitored value, to observe the small dose of heparin in treating pediatric critical analysis of the effect and clinical significance. Methods Selected our hospital treated 80 cases of pediatric critical care patients in February 2013 to February 2014, randomly divided into experimental group 40 cases and control group 40 cases, the control group using conventional clinical treatment, the experimental group on the basis of conventional treatment with heparin therapy, two groups of patients with D-dimer monitoring and other blood coagulation function, observed the therapeutic effect of heparin. Results Two groups of patients after treatment D-dimer were lower, effectively improved the blood coagulation function, the experimental treatment effect was obvious. Conclusion D-dimer monitoring and low-dose heparin for the treatment of pediatric critical care had obvious therapeutic effect, patients had less adverse reaction, worthy for clinical promotion and application.